AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
3 weeks ago • Google News
AC Immune Ltd (ACIU)
US$ 2.395-0.62%
Price Chart
Key Statistics
Market Cap
$ 157.64M
P/E Ratio
0.00
Revenue (TTM)
$ 28.3M
Volume
160.71K
52W High
$ 4.98
52W Low
$ 1.43
Dividend Yield
0.00%
Beta
1.62
Technicals
50-Day MA
1.8224
200-Day MA
2.7624
52 Week High
4.9782
52 Week Low
1.4299
About ACIU
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative dise.
Employees
133
Headquarters
Lausanne, Switzerland
CEO
Dr. Andrea Pfeifer Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg